Inhibition of the NF-κB signaling pathway mediates the anti-inflammatory effects of petrosaspongiolide M

被引:23
作者
Posadas, I
Terencio, MC
Randazzo, A
Gomez-Paloma, L
Payá, M
Alcaraz, MJ [1 ]
机构
[1] Univ Valencia, Fac Farm, Dept Farmacol, Avda Vicent Andres Estelles S-N, Burjassot 46100, Valencia, Spain
[2] Univ Salerno, Dipartimento Sci Farmaceut, I-84084 Fisciano, Salerno, Italy
关键词
NF-kappa B; zymosan; TNF alpha; petrosaspongiolide M; mouse air pouch; mouse peritoneal macrophages;
D O I
10.1016/S0006-2952(02)01659-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Petrosaspongiolide M (PT) is a potent secretory phospholipase A, inhibitor and anti-inflammatory agent. This marine metabolite reduced the production of nitrite, prostaglandin E,, and tumor necrosis factor-alpha in the Mouse air pouch injected with zymosan. These effects were also observed in mouse peritoneal macrophages stimulated with zymosan. Inhibition of these inflammatory mediators was related to reductions in inducible nitric oxide synthase, cyclo-oxygenase-2, and tumor necrosis factor-a expression. Since nuclear factor-kappaB (NF-kappaB) appears to play a central role in the transcriptional regulation of these proteins by macrophages, we investigated the effects of PT on this transcription factor. We found that PT was a potent inhibitor of the NF-kappaB pathway since at 1 muM it strongly decreased NF-kappaB-DNA binding in response to zymosan, in mouse peritoneal macrophages. Our study also indicated that PT could interfere with a key step ill NF-kappaB activation, the phosphorylation of IkappaBalpha, resulting in inhibition Of IkappaBalpha degradation. The control of a wide range of mediators by PT suggests a potentially wide therapeutic spectrum for this marine metabolite in inflammatory conditions. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:887 / 895
页数:9
相关论文
共 37 条
  • [1] NF-κB activation
    Abraham, E
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (04) : N100 - N104
  • [2] Regulation and inhibition of phospholipase A2
    Balsinde, J
    Balboa, MA
    Insel, PA
    Dennis, EA
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 : 175 - 189
  • [3] Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes
    Bidgood, MJ
    Jamal, OS
    Cunningham, AM
    Brooks, PM
    Scott, KF
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (05) : 2790 - 2797
  • [4] PHOSPHOLIPASE-A2 AND ARTHRITIS
    BOMALASKI, JS
    CLARK, MA
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (02): : 190 - 198
  • [5] Bondeson J, 1999, J IMMUNOL, V162, P2939
  • [6] Defining therapeutic targets by using adenovirus:: Blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators
    Bondeson, J
    Foxwell, B
    Brennan, F
    Feldmann, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) : 5668 - 5673
  • [7] Phospholipase A(2) and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics
    Bowton, DL
    Seeds, MC
    Fasano, MB
    Goldsmith, B
    Bass, DA
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (02) : 421 - 425
  • [8] The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein β (C/EBPβ) and C/EBPδ transcription factors
    Caivano, M
    Gorgoni, B
    Cohen, P
    Poli, V
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (52) : 48693 - 48701
  • [9] Inhibition of IκB kinase and IκB phosphorylation by 15-deoxy-Δ12,14-prostaglandin J2 in activated murine macrophages
    Castrillo, A
    Díaz-Guerra, MJM
    Hortelano, S
    Martín-Sanz, P
    Boscá, L
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (05) : 1692 - 1698
  • [10] Chan CC, 1999, J PHARMACOL EXP THER, V290, P551